Couples offered free assisted reproduction treatment have a very high chance of achieving a live birth within 4 years

Size: px
Start display at page:

Download "Couples offered free assisted reproduction treatment have a very high chance of achieving a live birth within 4 years"

Transcription

1 Couples offered free assisted reproduction treatment have a very high chance of achieving a live birth within 4 years Yechezkel Lande, M.D., a Daniel S. Seidman, M.D., b Ettie Maman, M.D., b Micha Baum, M.D., b Jehoshua Dor, M.D., b and Ariel Hourvitz, M.D. b a Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva; and b IVF Unit, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Objective: To assess the long-term success rate among couples with primary infertility offered unrestricted, free in vitro fertilization (IVF) treatments. Design: Historical prospective cohort study. Setting: University-based tertiary medical center with unlimited coverage of IVF for couples first two children. Patient(s): Women aged <35 years, with primary infertility, referred for their first IVF treatment to the Sheba Medical Center IVF unit between 2001 and Intervention(s): Relevant data were obtained from patient files and supplemented by a standardized telephone questionnaire. Main Outcome Measure(s): Pregnancies, live births, adoptions, divorces, and discontinuations of further treatment. Result(s): During the 5- to 7-year follow-up period, 95.5% of couples conceived, and 89.6% of couples gave birth to a live infant. Of these couples, 81.3% achieved a live birth within the first 4 years of the follow-up period, and 85.1% within eight treatment cycles. Of the 14 couples (10.4%) who did not give birth to a live infant, five adopted, two divorced, four are still undergoing IVF treatments, and three (1.8%) decided not to become parents. Conclusion(s): Young couples beginning IVF treatment in an environment free of economic hurdles can be reassured that they have an excellent chance (90%) of achieving a live birth within 4 years. When IVF is provided free of cost, very few couples discontinue treatment before a live birth is achieved. (Fertil Steril Ò 2011;95: Ó2011 by American Society for Reproductive Medicine.) Key Words: Cost-free cycles, IVF, live birth rate, long-term follow-up Infertile couples beginning in vitro fertilization (IVF) treatment will undergo an intense process filled with psychological burdens, physical discomfort, considerable expense, and medical procedures with risks and side effects (1 2). One of the major difficulties, particularly after repeated failure, is that we cannot accurately predict which treatment will be successful, how many treatment cycles are required, or what the estimated duration of treatment will be before a live birth is achieved. Most of the studies in the literature have assessed the success rate of IVF treatments per cycle (3 4). Some have reported the success as the cumulative pregnancy or live-birth rate over a series of three to six treatment cycles (5 10). These studies often do not take into consideration the possibility of having a spontaneous pregnancy during treatments. They also usually do not account for couples dropping out of fertility treatments for various psychological and economical reasons before a live birth is achieved. There are relatively few studies that report pregnancy and livebirth rates per duration of treatment. Our study evaluated infertile couples over the course of 5 to 7 years after initiating treatment. By using this methodology, we hoped to create a more accurate picture, allowing more realistic expectations for couples who come for consultation before beginning fertility treatment, to assess their chances of having a live child after a number of years. The situation in Israel is unique because IVF treatments are fully covered by the national health insurance and thus are provided free of charge to all women until their first two children are born. Israeli patients are offered easy access to IVF clinics where they can immediately undergo, when medically indicated, an unlimited number of IVF treatment cycles. We assumed that for infertile patients the chances of becoming pregnant and having a live child should be greater in Israel than in most other countries because the financial cost does not play a role in the patient s decision to obtain treatment (11). The results of our study may aid in evaluating the outcome of numerous consecutive IVF cycles and may help in assessing whether the success rates justify the financial expenditure beyond three to six IVF cycles. Received February 16, 2010; revised May 16, 2010; accepted June 1, 2010; published online July 19, Y.L. has nothing to disclose. D.S.S. has nothing to disclose. E.M. has nothing to disclose. M.B. has nothing to disclose. J.D. has nothing to disclose. A.H. has nothing to disclose. Reprint requests: Yechezkel Lande, M.D., Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, 39 Jabotinsky Street, Petach-Tikva, Israel (FAX: ; y.lande@gmail.com). MATERIALS AND METHODS This historical prospective cohort study included all couples referred to the Sheba Medical Center IVF unit who met the following inclusion criteria: [1] women aged %35 years at the time of referral, [2] women with primary infertility, [3] women with no IVF treatments before referral, [4] first IVF cycle performed between 2001 and 2002, and [5] a minimum of 12 months infertility before initiation of IVF treatment. Data were collected from the patients files, including basic clinical characteristics, infertility workup 568 Fertility and Sterility â Vol. 95, No. 2, February /$36.00 Copyright ª2011 American Society for Reproductive Medicine, Published by Elsevier Inc. doi: /j.fertnstert

2 and diagnosis, and treatment results. In addition, we contacted all women who met the inclusion criteria to obtain additional information regarding treatments performed in other institutions, spontaneous pregnancies and births, and discontinuations of IVF treatments due to divorce, adoption, or other reasons. All data received from the patients files and telephone interviews were collected in a database. The results of all treatment cycles were included in the analysis, regardless of the number of IVF units that provided the treatments. The primary outcome was a live birth, confirmed by medical file or telephone interview, and live births that occurred up to April 2008 were recorded. This study was approved by the institutional review board at Sheba Medical Center, which allowed retrospective review of patients files and administration of telephone questionnaires after informed consent. All statistical analyses were conducted with SPSS software, version 15 (SPSS, Inc., Chicago, IL). The cumulative probability of the first live birth during the study period was estimated using the Kaplan-Meier method, according to the IVF cycle number and according to years of treatment. To evaluate differences between clinical characteristics of the study group and couples who were lost to follow up or refused to participate, we used a t-test. A two-sided P<.05 was considered statistically significant. RESULTS Between January 2001 and December 2002, 171 couples with primary infertility began their first IVF cycle at the Sheba Medical Center fertility unit and met the study inclusion criteria. Of these 171 couples, 6 refused to participate in the telephone questionnaire (3.5%), and 31 couples were lost to follow-up evaluation and could not be reached by telephone (18.3%). The study cohort therefore included 134 couples who agreed to participate in this study (78.4%) (Fig. 1). We evaluated the group of couples who refused to participate or were lost to follow up and found no statistically significant differences in their basic clinical characteristics compared with the study group (Table 1). During the follow-up period of 5 to 7 years, 128 (95.5%) couples conceived and 120 (89.6%) gave birth to a live child. Of the live births, 19.2% were twins. There were no triplet births in this cohort. Over 60% of the patients achieved a live birth within the first year of the follow up period; 85.1% and 88.8% achieved a live birth within 4 and 6 years of follow-up, respectively (Fig. 2A). Seventy-three patients achieved a live birth after only three treatment cycles (54.5%) and 109 (81.3%) after eight treatment cycles. The remaining 11 live births were achieved by cycle 19 (Table 2; Fig. 2B). The majority of live births were attained by IVF or intracytoplasmic sperm injection (ICSI) cycles (76.7%) and with frozen-thawed embryos (9.2%). Eleven (9.2%) live births resulted from spontaneous pregnancies, three (2.5%) from IVF with donor sperm, two (1.7%) from intrauterine insemination with donor sperm, and one (0.8%) from egg donation. During the long-term follow-up period, 14 couples (10.4%) did not give birth to a live child. Ten couples discontinued treatments without achieving a live birth, and four are still continuing fertility treatments. Of the couples who ceased treatments, five chose to adopt, two stopped infertility treatments due to divorce, and three made the choice to give up on parenthood and therefore discontinued treatments. Only two couples are still pursuing IVF treatments seriously. Of the other two couples who claimed to be continuing IVF treatments, in reality they did not complete more than three cycles over the span of the long-term follow-up period. DISCUSSION Our study provides unprecedented cumulative live-birth rates (CLBR) for young infertile couples evaluated over 5 to 7 years. The results show impressive success rates of 89.6%, with most of the live births achieved within the first eight treatment cycles. Although the majority of live births occurred within the first year of initiating treatment, it appears that a minimum period of 4 years, and possibly even 6 years, may be necessary to truly take advantage of the chance of attaining a live birth with repeated IVF cycles (see Fig. 2A). A previous study, performed in the Netherlands (12), included 1,456 couples who initiated IVF treatments between 1996 and 2000, whose live-birth rates were evaluated and recorded through September The CLBR found for women aged <35 years was 64.6%. It is interesting that 90% of the pregnancies were achieved within the first three cycles, and only 5.2% of the couples continued up to a sixth cycle. The lower CLBR can therefore be explained by the high dropout rate in the Netherlands after three to six cycles due to lack of insurance coverage. Another limitation was that the clinic conducting the study performed a maximum of six cycles per couple. A recent study performed in our institution (13) assessed the yield of high-order consecutive IVF treatments. The cumulative delivery rates after 14 consecutive cycles reached 87%, and each additional cycle increased the delivery rates. This emphasizes the improved success rates for couples who continue IVF treatments for a long period of time. We therefore found it necessary to assess in a cohort analysis how many couples actually continued treatment until a live birth was achieved and how many dropped out from treatment. It is interesting that, in our study, only six couples from a cohort of 134 dropped out and did not complete six treatment cycles (4.5% dropout rate). The low dropout rate may explain the high CLBR after six cycles of 73.1%. The remaining eight couples who did not achieve a live birth performed between 10 to 20 cycles, and two of them are still continuing IVF treatment despite their long lack of success. Of the 134 couples who were included in this study, 11 (8.2%) achieved a spontaneous live birth, and 20 achieved a live birth from IVF treatments completed in other institutions (14.9%). We must emphasize that the inclusion of spontaneous live births and live births achieved by IVF in other institutions is unique to our study. Other studies have considered such couples to be dropouts, but we are reporting them as succeeding in achieving a live birth. This difference may partially account for our higher live-birth rate in comparison with previous studies (12, 14). The CLBR, regardless of how or where the births were achieved, is the information that most couples seek when contemplating whether to continue with IVF treatment. One of the limitations of our study is that, of the 171 couples who met the inclusion criteria, 37 refused to answer the telephone questionnaire or were lost to follow-up evaluation and could not be reached by telephone; they were therefore not included in this study. When the clinical characteristics of the nonresponders were compared to the respondents, no significant differences were found (Table 1). Therefore, we concluded that the respondents are representative of all the patients who met the inclusion criteria. When the files of the nonresponders were reviewed, we found that 19 of the 37 couples had achieved a live birth during IVF treatments at Sheba Medical Center. If we estimate that the remaining 18 couples who discontinued treatments and were lost to follow-up evaluation had a similar outcome as the couples in our study group, 5.5 couples would have achieved a live birth from treatments in other institutions and 3.0 from spontaneous pregnancies. The total CLBR from the entire cohort of 171 would then be 86.3%, similar to the rate in our study group. Even if we assume that there were no live births in the group who discontinued treatments at Sheba without achieving a live birth and were lost to follow up, the total CLBR Fertility and Sterility â 569

3 FIGURE 1 Long-term follow-up of young women with primary infertility beginning IVF treatments at Sheba Medical Center from 2001 to Women <35 years with primary infertility beginning IVF treatments at Sheba medical center during Lost to follow up 140 Contacted by phone 6 Declined to participate 134 Women were included in the study. 108 Live births achieved Figure through 2 IVF 10 Spontaneous live births 14 Did not achieve a live birth 10 Discontinued IVF treatments 4 Continuing IVF treatments 5 Adopted 2 Divorced 3 Gave up on parenthood still remains 81.3% a much higher rate than reported in other previous studies. In a recent study, Malizia et al. (14) reported a CLBR of 65% after six consecutive cycles in patients under 35. There was no significant increase in this rate when more than six cycles were conducted. This was explained by the fact that very few couples continued past six cycles due to lack of insurance coverage. Out of over 3,000 couples who did not achieve a live birth, only 276 remained for all six cycles. This emphasizes the high dropout rate (over 90%) from continuing IVF treatments in countries where insurance coverage is limited. The low dropout rate in our study can be explained by two main factors. First, Israel s national health system offers unlimited coverage for IVF treatments. When the financial burden of IVF treatments is neutralized, the dropout rate appears to decline drastically. Second, our study included all IVF cycles that were performed by the participant couples, not just the cycles performed in a single institution. It is possible that if other studies had also accounted for cycles performed in other institutions their dropout rates would have been much lower as well. A recent study performed at Boston IVF (15) to determine why insured patients drop out of IVF in the United States suggested that the dropout rate before a live birth is achieved reaches over 50% even in situations where there is full financial coverage for IVF treatments. They concluded that the psychological burden and stress were the most common reasons for terminating treatment, not necessarily the lack of financial coverage. In contrast, 570 Lande et al. Live-birth rates for free IVF Vol. 95, No. 2, February 2011

4 i l i t i i t ) TABLE 1 Clinical characteristics of the study group compared to characteristics of couples who were lost to follow-up or refused to participate. Characteristic Study group (mean ± SD) Lost to follow-up (mean ± SD) P value Patient age (y) (NS) Duration of infertility (y) (NS) FSH day 3 (miu/l) (NS) LH day 3 (miu/l) (NS) Sperm volume (ml) (NS) Sperm count ( 10 6 /ml) (NS) Sperm motility (%) (NS) Note: FSH ¼ follicle-stimulating hormone; LH ¼ luteinizing hormone; SD ¼ standard deviation. our study found the lack of financial burden to be associated with a much lower dropout rate. Of course, it is likely that full financial coverage in our study was not the only reason for the high CLBR after persistent IVF treatment. For historical, religious, and cultural reasons, giving birth to children is of supreme importance in Israeli society, and childlessness is viewed as a serious disability (16). This in turn may explain the generosity of the Israeli national health insurance in providing comprehensive financial coverage for IVF treatment for the first two children, and may also explain why our dropout rates were so low compared with other studies. A study from the mid-1980s found that cumulative pregnancy rates after six IVF cycles reached 60%, with a relatively constant 15% pregnancy rate per cycle. They predicted that the pregnancy rate remains constant even for high-order consecutive IVF cycles (17). This is contrary to the finding in our study that live-birth rates indeed remained relatively constant until the eighth cycle, but from the ninth cycle they seemed to decline drastically (see FIGURE 2 (A) Kaplan-Meier curve for cumulative live-birth rates per years of follow-up. (B) Kaplan-Meier curve for cumulative live-birth rates per embryo transfer. h ( % r v e B y o f L P r o b a b Years of Follow Up Live Birth (%) Probability of Cycle Number Fertility and Sterility â 571

5 TABLE 2 Cumulative live birth rates (CLBR) per embryo transfer cycle. ET Patients who entered cycle, n Patients who achieved a live birth, n Live birth rate per cycle, % CLBR per cycle, % Table 2, Fig. 2B). Similarly, a study from our institution from 1996 (10) reported that the CLBR of IVF reached a plateau after six cycles, and therefore insurance companies should cover treatments until the sixth cycle. In our present study, it appears that the plateau begins after the completion of eight to nine cycles (see Table 2, Fig. 2B). It should be noted that the patients included in this study began IVF treatments nearly a decade ago. Over the past decade, IVF success rates have improved significantly, with higher live-birth rates per cycle. Patients initiating IVF today, in a cost-free environment, can probably be expected to have an even higher live-birth rate within a shorter period of time and with fewer treatment cycles required. The CLBR found in our study is very high, and almost 90% of the patients achieved their desired live birth within the follow-up period. This high rate can be explained by two main factors. First, the low dropout rate from continuing IVF treatments in Israel is likely due in a large part to the full financial coverage offered for practically unlimited IVF treatments. Second, this study accounts for spontaneous births as well as births achieved from treatments performed in other institutions. According to our new findings, we can conclude that in a cost-free environment young women beginning IVF treatments can be reassured that they have a very high chance (near 90%) of becoming pregnant and achieving a live birth within 4 to 6 years. REFERENCES 1. Peddie VL, van Teijlingen E, Bhattacharya S. A qualitative study of women s decision-making at the end of IVF treatment. Hum Reprod 2005;20: Bryson CA, Sykes DH, Traub AI. In vitro fertilization: a long-term follow-up after treatment failure. Hum Fertil (Camb) 2000;3: Society for Assisted Reproductive Technology; American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2007;87: Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE. European IVF Monitoring Programme (EIM), for the European society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009;24: Olivius K, Friden B, Lundin K, Bergh C. Cumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2002;77: Engmann L, Maconochie N, Bekir JS, Jacobs HS, Tan SL. Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment of overall and age-specific success rates? Br J Obstet Gynaecol 1999;106: de Jong D, Eijkemans MJ, Beckers NG, Pruijsten RV, Fauser BC, Macklon NS. The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort? J Assist Reprod Genet 2002;19: Shulman A, Menashe K, Laor A, Levron J, Madgar Y, Bider D, et al. Cumulative pregnancy rate following IVF and intracytoplasmatic sperm injection with ejaculated and testicular spermatozoa. Reprod Biomed Online 2002;4: Alsalili M, Yuzpe A, Tummon I, Parker J, Martin J, Daniel S, et al. Cumulative pregnancy rates and pregnancy outcome after in-vitro fertilization: >5000 cycles at one centre. Hum Reprod 1995;10: Dor J, Seidman DS, Ben-Shlomo I, Levran D, Ben- Rafael Z, Mashiach S. Cumulative pregnancy rate following IVF: the significance of age and infertility aetiology. Hum Reprod 1996;11: Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med 2002;347: Witsenburg C, Dieben S, Van der Westerlaken L, Verburg H, Naaktgeboren N. Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2005;84: Elizur SE, Lerner-Geva L, Levron J, Shulman A, Bider D, Dor J. Cumulative live birth rate following in vitro fertilization: study of 5,310 cycles. Gynecol Endocrinol 2006;22: Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N. Engl J Med 2009;360: Domar AD, Smith K, Conboy L, Iannone M, Alper M. A prospective investigation into the reasonswhy insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. Published online July 8, Birenbaum-Carmeli D, Dirnfeld M. In vitro fertilisation policy in Israel and women s perspectives: the more the better? Reprod Health Matters 2008;16: Guzick DS, Wilkes C, Jones HW Jr. Cumulative pregnancy rates for in vitro fertilization. Fertil Steril 1986;46: Lande et al. Live-birth rates for free IVF Vol. 95, No. 2, February 2011

Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection

Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection Cynthia Witsenburg, M.D., Sandra Dieben, M.D., Lucette Van der Westerlaken, M.Sc.,

More information

Cumulative Live-Birth Rates after In Vitro Fertilization

Cumulative Live-Birth Rates after In Vitro Fertilization The new england journal of medicine original article Cumulative Live-Birth Rates after In Vitro Fertilization Beth A. Malizia, M.D., Michele R. Hacker, Sc.D., M.S.P.H., and Alan S. Penzias, M.D. ABSTRACT

More information

Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS

Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS Judy E. Stern, Ph.D., a Morton B. Brown, Ph.D., b Barbara Luke,

More information

Cumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles

Cumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles FERTILITY AND STERILITY VOL. 77, NO. 3, MARCH 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Cumulative probability

More information

Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles

Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles Nicolas Garrido, Ph.D., M.Sc., a Jose Bellver, M.D., a Jose Remohí,

More information

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for

More information

Abstract. Introduction. Materials and methods

Abstract. Introduction. Materials and methods RBMOnline - Vol 10. No 5. 2005 645 649 Reproductive BioMedicine Online; www.rbmonline.com/article/1518 on web 18 March 2005 Article Factors predicting IVF treatment outcome: a multivariate analysis of

More information

Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles

Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles original article Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles Barbara Luke, Sc.D., M.P.H., Morton B. Brown, Ph.D., Ethan Wantman, M.B.A., Avi Lederman, B.A., William Gibbons,

More information

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 24 August 2009

Abstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online;  on web 24 August 2009 RBMOnline - Vol 19. No 4. 2009 599 603 Reproductive BioMedicine Online; www.rbmonline.com/article/3872 on web 24 August 2009 Article Assisted reproduction in women over 40 years of age: how old is too

More information

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE Human Reproduction, Vol.1, No.1 pp. 1 21, 2009 doi:10.1093/humrep/dep035 Hum. Reprod. Advance Access published February 18, 2009 ORIGINAL ARTICLE ESHRE Assisted reproductive technology and intrauterine

More information

Artigo original/original Article

Artigo original/original Article Artigo original/original Article Análise do registo português de procriação medicamente assistida: 1997-2005 A long-term analysis of the Portuguese assisted reproductive technologies data registry 1997-2005

More information

Research Article Cumulative Delivery Rate after Providing Full Reimbursement In Vitro Fertilization Programme: A 6-Years Survey

Research Article Cumulative Delivery Rate after Providing Full Reimbursement In Vitro Fertilization Programme: A 6-Years Survey Hindawi Publishing Corporation BioMed Research International Volume 2014, Article ID 850478, 8 pages http://dx.doi.org/10.1155/2014/850478 Research Article Cumulative Delivery Rate after Providing Full

More information

Articles Cumulative pregnancy rate following IVF and intracytoplasmatic sperm injection with ejaculated and testicular spermatozoa

Articles Cumulative pregnancy rate following IVF and intracytoplasmatic sperm injection with ejaculated and testicular spermatozoa RBMOnline - Vol 4. No 2. 151 156 Reproductive BioMedicine Online; www.rbmonline.com/article/433 on web 31 January 2002 Articles Cumulative pregnancy rate following IVF and intracytoplasmatic sperm injection

More information

Nicolas Garrido, Ph.D., Jose Bellver, M.D., Jose Remohı, M.D., Carlos Simon, M.D., and Antonio Pellicer, M.D.

Nicolas Garrido, Ph.D., Jose Bellver, M.D., Jose Remohı, M.D., Carlos Simon, M.D., and Antonio Pellicer, M.D. ASSISTED REPRODUCTION Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF

More information

*Correspondence address.

*Correspondence address. Human Reproduction, Vol.31, No.1 pp. 93 99, 2016 Advanced Access publication on November 3, 2015 doi:10.1093/humrep/dev270 ORIGINAL ARTICLE Infertility How do cumulative live birth rates and cumulative

More information

IVF treatment should not be postponed for patients with high basal FSH concentrations

IVF treatment should not be postponed for patients with high basal FSH concentrations Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie

More information

UvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication

UvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication UvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication Citation for published version (APA): Custers, I. M. (2013). Intrauterine insemination:

More information

Live birth outcome, spontaneous pregnancy and adoption up to five years after undergoing assisted reproductive technology treatment

Live birth outcome, spontaneous pregnancy and adoption up to five years after undergoing assisted reproductive technology treatment AOGS ORIGINAL RESEARCH ARTICLE Live birth outcome, spontaneous pregnancy and adoption up to five years after undergoing assisted reproductive technology treatment HELENA VOLGSTEN 1,2 & LONE SCHMIDT 3 1

More information

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

COMMISSIONING POLICY. Tertiary treatment for assisted conception services Final Version COMMISSIONING POLICY Tertiary treatment for assisted conception services Designated providers for patients registered with a Worcestershire GP BMI The Priory Hospital, Birmingham - 1 - Commissioning

More information

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception 1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund

More information

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION

More information

Cumulative live birth rates after one or more complete cycles of IVF: a. population-based study of linked cycle data from 178,898 women

Cumulative live birth rates after one or more complete cycles of IVF: a. population-based study of linked cycle data from 178,898 women 1 2 Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women 3 David J McLernon 1,*, Abha Maheshwari 2, Amanda J Lee 3, Siladitya

More information

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO

More information

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Births following fertility treatment in the GUI infant cohort.  Aisling Murray Growing Up in Ireland, ESRI Births following fertility treatment in the GUI infant cohort www.growingup.ie Aisling Murray Growing Up in Ireland, ESRI About GUI Two cohorts: birth (9 months) and middle childhood (9 years) Current

More information

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review

More information

CLINICAL ASSISTED REPRODUCTION

CLINICAL ASSISTED REPRODUCTION CLINICAL ASSISTED REPRODUCTION IVF Births and Pregnancies: An Exploration of Two Methods of Assessment Using Life-Table Analysis R. DEONANDAN, 1,4 M. K. CAMPBELL, 1 T. OSTBYE, 2 I. TUMMON, 3 and J. ROBERTSON

More information

WHAT IS A PATIENT CARE ADVOCATE?

WHAT IS A PATIENT CARE ADVOCATE? WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing

More information

Abstract. Introduction. Materials and methods. Patients and methods

Abstract. Introduction. Materials and methods. Patients and methods RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos

More information

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort

A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,

More information

MONITORING ASSISTED REPRODUCTIVE TECHNOLOGIES ROMANIAN EXPERIENCE

MONITORING ASSISTED REPRODUCTIVE TECHNOLOGIES ROMANIAN EXPERIENCE MONITORING ASSISTED REPRODUCTIVE TECHNOLOGIES ROMANIAN EXPERIENCE ANCA CORICOVAC 1, LAURA DRACEA 2 1,2 Carol Davila University of Medicine and Pharmacy Bucharest, 1,2 Gynera Fertility Clinic Bucharest

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

Adoption and Foster Care

Adoption and Foster Care GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.

More information

Incomplete working draft, please do not quote without authors permission

Incomplete working draft, please do not quote without authors permission Will fertility of Danish women remain stable due to assisted reproduction? Assessing the role of assisted reproduction in sustaining cohort fertility rates Incomplete working draft, please do not quote

More information

European IVF Monitoring (EIM) Year: 2013

European IVF Monitoring (EIM) Year: 2013 European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility

More information

Prospective longitudinal cohort study on cumulative 5-year delivery and adoption rates among 1338 couples initiating infertility treatment

Prospective longitudinal cohort study on cumulative 5-year delivery and adoption rates among 1338 couples initiating infertility treatment Human Reproduction, Vol.24, No.4 pp. 991 999, 2009 Advanced Access publication on January 9, 2009 doi:10.1093/humrep/den463 ORIGINAL ARTICLE Reproductive epidemiology Prospective longitudinal cohort study

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years Page 1 of 9 05/29501 Trends in the use of donor gametes (sperm and eggs) Donor assisted conception

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in

More information

HAL author manuscript. Estimating the success of an in vitro fertilization programme. using multiple imputation

HAL author manuscript. Estimating the success of an in vitro fertilization programme. using multiple imputation HAL author manuscript Human Reproduction / Human Reproduction (Oxford) 2008;23(1):187-92 Estimating the success of an in vitro fertilization programme using multiple imputation N. Soullier 1,2,3, J. Bouyer

More information

Use of donor semen in the treatment of

Use of donor semen in the treatment of Use of donor semen in the treatment of male infertility Where is the evidence? Max H.J.M. Curfs Isala clinics Zwolle, The Netherlands Strength of evidence Systematic review Meta-analysis RCT 1A 1A 1B

More information

International Federation of Fertility Societies. Global Standards of Infertility Care

International Federation of Fertility Societies. Global Standards of Infertility Care International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author

More information

The final publication is available at

The final publication is available at Smith, A. D. A. C., Tilling, K., Nelson, S. M. and Lawlor, D. A. (2015) Live-birth rate associated with repeat in vitro fertilization treatment cycles. Journal of the American Medical Association, 314

More information

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner

More information

INTRACYTOPLASMIC SPERM INJECTION

INTRACYTOPLASMIC SPERM INJECTION 1 Background... 2 2 Male Factor Infertility... 2 3 ICSI... 3 4 Surgical sperm aspiration... 4 5 What is the chance of success?... 6 6 What are the risks?... 7 M Rajkhowa, October 2004 Authorised by V Kay

More information

Haringey CCG Fertility Policy April 2014

Haringey CCG Fertility Policy April 2014 Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:

More information

Possibilities Plan. Access to the care you need.

Possibilities Plan. Access to the care you need. Possibilities Plan If you do not have insurance or have insurance but lack coverage for infertility services and are concerned about the cost of infertility services, The Center for Advanced Reproductive

More information

Fertility treatment in trends and figures

Fertility treatment in trends and figures Fertility treatment in 2010 trends and figures Contents Page No: Foreword by the Chair of the HFEA 3 Summary 4 Section 1: Overview How many fertility clinics were there in the UK in 2010? 6 How many women

More information

T39: Fertility Policy Checklist

T39: Fertility Policy Checklist Patient Name: Address: Date of Birth: NHS Number: Consultant/Service to whom referral will be made: Institution Lifestyle Information Latest BMI: Latest BP: Smoking Status: Has the patient been referred

More information

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology

The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie

More information

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has

More information

Biology of fertility control. Higher Human Biology

Biology of fertility control. Higher Human Biology Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 9 A UGUST 7, 1998 NUMBER 9 REDUCING THE RISK OF MULTIPLE BIRTHS BY TRANSFER OF TWO EMBRYOS AFTER IN VITRO

More information

European IVF Monitoring (EIM) Year: 2012

European IVF Monitoring (EIM) Year: 2012 European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone

More information

Assisted Reproductive Technologies

Assisted Reproductive Technologies Assisted Reproductive Technologies ADDENDUM TO THE STEP REPORT August, 26 Submitted to: The Alberta Health Technologies Decision Process Research & Innovation Branch Strategic Planning & Policy Development

More information

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study

Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study . M.,nopause FERTILITY AND STERILITY Vol. 63, No.3, March 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. Endometrial blood flow response to hormone

More information

Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology. Andrew Fisher, BSE, MS4.

Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology. Andrew Fisher, BSE, MS4. Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology Andrew Fisher, BSE, MS4 February 10, 2014 Submitted here for consideration for the Perelman School of Medicine

More information

Top 10 questions in fertility

Top 10 questions in fertility Top 10 questions in fertility Mr Rehan Salim MD MRCOG Head of Reproductive Medicine Consultant Gynaecologist & Subspecialist in Reproductive Medicine Imperial College NHS Trust Learning objectives Patient

More information

Time to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia

Time to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia Time to improvement in semen parameters after microsurgical varicocelectomy in men with severe oligospermia Thomas A. Masterson; Aubrey B. Greer; Ranjith Ramasamy University of Miami, Miami, FL, United

More information

2017 United HealthCare Services, Inc.

2017 United HealthCare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017

More information

Clinical Policy Committee

Clinical Policy Committee Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year

More information

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017 Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services, in Shropshire and Telford and Wrekin Owner(s) Version No. Director of

More information

The Science and Psychology of Infertility

The Science and Psychology of Infertility University of Massachusetts Medical School escholarship@umms Women s Health Research Faculty Publications Women's Faculty Committee 6-25-2014 The Science and Psychology of Infertility Julia V. Johnson

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2. COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of

More information

Articles Follow-up of children born after assisted reproductive technologies

Articles Follow-up of children born after assisted reproductive technologies RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael

More information

Risk of treatment failure: psychological consequences and quality of life. Infertility. Infertility a social situation. Non-event, a non-transition

Risk of treatment failure: psychological consequences and quality of life. Infertility. Infertility a social situation. Non-event, a non-transition Risk of treatment failure: psychological consequences and quality of life Lone Schmidt Associate Professor, DMSci, PhD L.Schmidt@pubhealth.ku.dk ESHRE Campus 2008 Lübeck, 18th January 2008 Dias 1 Infertility

More information

Family planning, fertility awareness and knowledge about Italian legislation on assisted reproduction among Italian academic students

Family planning, fertility awareness and knowledge about Italian legislation on assisted reproduction among Italian academic students Reproductive BioMedicine Online (2010) 20, 873 879 www.sciencedirect.com www.rbmonline.com ARTICLE Family planning, fertility awareness and knowledge about Italian legislation on assisted reproduction

More information

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur?

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,

More information

Recommended Interim Policy Statement 150: Assisted Conception Services

Recommended Interim Policy Statement 150: Assisted Conception Services Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations

More information

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial Esther M E W Heijnen, Marinus J C Eijkemans, Cora De Klerk, Suzanne Polinder, Nicole G M Beckers, Ellen R Klinkert,

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

INTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen.

INTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen. TABLE OF CONTENTS INTRODUCTION INTRODUCTION 1 MEN Fertility Risks 2 Fertility Preservation Options 3 Possible Fertility Outcomes 4 Parenthood After Cancer Options 5 Important Tips for Men 6 WOMEN Fertility

More information

IVF. NHS North West London CCGs

IVF. NHS North West London CCGs IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from

More information

Assisted Reproductive Technologies

Assisted Reproductive Technologies Assisted Reproductive Technologies Textbook pages 224 231 Section 6.3 Summary Before You Read What do you think the phrase test-tube baby refers to? Write your ideas on the lines below. Mark the Text Check

More information

L B. IN VITRO FERTILIZATION Prof. Levron Prof. Bider

L B. IN VITRO FERTILIZATION Prof. Levron Prof. Bider L B IN VITRO FERTILIZATION Prof. Levron Prof. Bider Egg Donation Surrogacy IVF PGD Fertility Treatments Infertile Couple Evaluation Male Infertility Treatment L B IN VITRO FERTILIZATION Prof. Levron Prof.

More information

Fertility assessment and assisted conception

Fertility assessment and assisted conception Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.

More information

Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over

Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 40 and over ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 217;44(2):111-117 Predictors of live birth and pregnancy success after in vitro fertilization in infertile women aged 4 and over Hye

More information

The Gay Woman s Guide to Becoming a Mom PATH2PARENTHOOD. path2parenthood.org

The Gay Woman s Guide to Becoming a Mom PATH2PARENTHOOD. path2parenthood.org The Gay Woman s Guide to Becoming a Mom PATH2PARENTHOOD path2parenthood.org For lesbians, there are a number of viable routes that can be considered when achieving motherhood is the goal. Whether you are

More information

Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility

More information

The evidence for insemination versus intercourse or IVF

The evidence for insemination versus intercourse or IVF To inseminate or not: that s the question! The evidence for insemination versus intercourse or IVF B.Cohlen, Genk 2009 There are believers and non-believers Ovarian stimulation protocols (anti-oestrogens,

More information

Sperm Donation - Information for Donors

Sperm Donation - Information for Donors Sperm Donation - Information for Donors The donation of sperm to help someone to have a child is one of the most generous gifts anyone can give. Many donors feel a sense of pride, knowing the joy they

More information

Therapeutic Sperm Banking

Therapeutic Sperm Banking Therapeutic Sperm Banking An Option for Preserving Male Fertility Andrology Laboratory and Reproductive Tissue Bank Information For Patients Men undergoing cancer treatment, including certain types of

More information

EQUINE INTRACYTOPLASMIC SPERM INJECTION PROGRAM

EQUINE INTRACYTOPLASMIC SPERM INJECTION PROGRAM COLLEGE OF VETERINARY MEDICINE & BIOMEDICAL SCIENCES Department of Large Animal Clinical Sciences 4475 TAMU EQUINE INTRACYTOPLASMIC SPERM INJECTION PROGRAM Section of Theriogenology Veterinary Medical

More information

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome

More information

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? Vitaly A. Kushnir MD Center for Human Reproduction New York City Milestones

More information

Body Mass Index and success rate of IVF

Body Mass Index and success rate of IVF Journal of Family and Reproductive Health Summer 2007; (): 4-46 Body Mass Index and success rate of IVF Farshad Savadkouhi M.D., Mina Jafarabadi 2 M.D., Fatemeh Ramezanzadeh 2 M.D. Military University

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

British Journal of Obstetrics and Gynaecology February 1999, Vol106, pp

British Journal of Obstetrics and Gynaecology February 1999, Vol106, pp British Journal of Obstetrics and Gynaecology February 999, Vol06, pp. 65-70 Cumulative probability of clinical pregnancy and live birth after a multiple cycle IVF package: a more realistic assessment

More information

CONTROVERSY: INSURANCE COVERAGE

CONTROVERSY: INSURANCE COVERAGE CONTROVERSY: INSURANCE COVERAGE FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A.

More information

Fertility Policy. December Introduction

Fertility Policy. December Introduction Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services

More information

Of Competitive Pressures and Care Quality: Infertility Treatment Case

Of Competitive Pressures and Care Quality: Infertility Treatment Case Of Competitive Pressures and Care Quality: Infertility Treatment Case Helen Schneider Department of Economics, University of Texas at Austin Importance of the Study About 11 percent of American women 15

More information

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director Brighton & Hove CCG PLS CONFERENCE 2016 Dr Carole Gilling-Smith Medical Director FERTILITY CHALLENGES IN THE NHS A TERTIARY CARE PERSPECTIVE LEARNING OBJECTIVES Understand the pathways through assisted

More information

Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj

More information

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G

More information

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No: Version: 2 Ratified by: EMSCGP006V2 EMSCG Date ratified:

More information